Immuron Receives European Patent Notification on Drug Composition to Treat Clostridioides difficile Associated DiseaseGlobeNewsWire • 07/07/22
Immuron US DoD Naval Medical Research Center Submits IND Application for New Campylobacter ETEC TherapeuticGlobeNewsWire • 05/11/22
US Department of Defense Uniformed Services University Clinical Evaluation of Travelan™GlobeNewsWire • 05/09/22
Immuron new MTEC project proposal “Development of Oral Immunotherapy for the Prevention of Bacterial Diarrheal Disease”GlobeNewsWire • 04/19/22
Immuron Receives European Patent on Drug Composition to Treat Travelers' DiarrheaGlobeNewsWire • 01/13/22
Immuron Receives A$6.2 Million Award from U.S. DoD to Clinically Evaluate a Military Strength Dosing Regimen for TravelanGlobeNewsWire • 01/12/22
Immuron to Participate in H.C. Wainwright & Co. BioConnect 2021 Virtual ConferenceGlobeNewsWire • 01/11/21